Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

VHTvsFTXHETF Comparison

ETF 1
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
+0.32%
VS
ETF 2
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
+0.32%

Vanguard Health Care ETF (VHT) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. VHT's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, FTXH's top sector exposures are Healthcare,  VHT is less expensive with a Total Expense Ratio (TER) of 0.09%, versus 0.6% for FTXH. VHT is up 6.79% year-to-date (YTD) with -$84M in YTD flows. FTXH performs better with 18.66% YTD performance, and +$764M in YTD flows. Run a side-by-side ETF comparison of VHT and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

VHT vs FTXH performance and flow charts

Performance

0.02.04.06.08.0%Jun 24Jul 1Jul 8Jul 15Jul 22

Cumulative Flows

0 M200 M400 M600 M800 MJun 24Jul 1Jul 8Jul 15Jul 22

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/24/2026
1M3MYTD1Y3Y5Y
Perf.
VHT
FTXH
+5.71%+6.06%
+13.44%+16.13%
+6.79%+18.66%
+24.07%+45.53%
+27.86%+52.27%
+29.60%+58.82%
Flows
VHT
FTXH
+$148M+$754M
+$135M+$756M
-$84M+$764M
-$322M+$767M
-$2.43B+$756M
-$679M+$759M
Volatility and drawdown
3M1Y3Y5Y
Volatility
VHT
FTXH
+17.46%+17.99%
+15.29%+17.07%
+14.31%+16.57%
+15.40%+16.09%
Max drawdown
VHT
FTXH
-3.84%-4.43%
-10.39%-7.50%
-16.88%-19.32%
-17.77%-19.32%
Max drawdown duration
VHT
FTXH
17d17d
169d99d
435d393d
767d393d
Trading data

Create an account to view trading data

Join for free
VHT
FTXH
Last sale
7/27/2026 at 3:47 PM
$307.75
$39.45
Previous close
07/24/2026
$305.07
$38.97
Consolidated volume
07/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
VHT
FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/27/2026 at 3:47 PM
Live
Closed
VHT
FTXH
Last price
$307.75
$39.45
1D performance
+0.88%
+1.23%
AuM$18.27 B$791.84 M
E/R0.09%0.6%
Characteristics
VHT
FTXH
Management strategyPassivePassive
ProviderVanguardFirst Trust
BenchmarkMSCI US IMI Health Care 25/50 IndexNASDAQ US Smart Pharmaceuticals Index
N° of holdings41950
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2004September 20, 2016
ESGNoNo
Advertisement
Exposure

Countries

VHT
USA
96.86%
Other
3.14%
FTXH
USA
95.49%
Other
4.51%

Sectors

VHT
Healthcare
97.39%
Other
2.61%
FTXH
Healthcare
99.86%
Other
0.14%
Advertisement

Diversification

VHT

Total weight of top 15 holdings out of 15

61.42%
FTXH

Total weight of top 15 holdings out of 15

66.57%

Top 15 holdings

Data as of June 30, 2026
VHT
Eli Lilly & Co.
14.16%
Johnson & Johnson
8.87%
AbbVie, Inc.
6.54%
UnitedHealth Group, Inc.
5.55%
Merck & Co., Inc.
4.67%
Amgen, Inc.
2.87%
Thermo Fisher Scientific, Inc.
2.74%
Abbott Laboratories
2.32%
Gilead Sciences, Inc.
2.31%
Intuitive Surgical, Inc.
2.08%
Pfizer Inc.
2.01%
CVS Health Corp.
1.93%
Vertex Pharmaceuticals, Inc.
1.86%
Danaher Corp.
1.78%
Bristol Myers Squibb Co.
1.73%
FTXH
Eli Lilly & Co.
7.74%
AbbVie, Inc.
7.39%
Johnson & Johnson
6.98%
Merck & Co., Inc.
6.92%
Bristol Myers Squibb Co.
6.18%
Biogen, Inc.
3.73%
Viatris, Inc.
3.70%
Cardinal Health, Inc.
3.54%
Vertex Pharmaceuticals, Inc.
3.42%
Amgen, Inc.
3.18%
Pfizer Inc.
2.95%
Gilead Sciences, Inc.
2.89%
United Therapeutics Corp.
2.76%
Regeneron Pharmaceuticals, Inc.
2.73%
Jazz Pharmaceuticals Plc
2.46%
Frequently asked questions about VHT and FTXH

How have the VHT and FTXH ETFs performed in 2026?

As of July 24, 2026, VHT is up 6.79% year-to-date (YTD), while FTXH has returned 18.66%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: VHT or FTXH?

Year-to-date, the VHT ETF saw -$84M in flows, compared to +$764M for FTXH.

Which ETF is more volatile: VHT or FTXH?

Over the past year, VHT had a volatility of 15.29%, while FTXH experienced 17.07%.

Which ETF is bigger: VHT or FTXH?

As of July 24, 2026, VHT holds $18.27 B in assets under management (AUM), while FTXH manages $791.84 M.

What sectors do the VHT and FTXH ETFs invest in?

VHT leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the VHT ETF and FTXH ETF?

VHT top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. FTXH holds in its top three: Eli Lilly & Co., AbbVie, Inc. and Johnson & Johnson.

Which ETF is more diversified: VHT or FTXH?

VHT holds 419 securities with 61.42% of its assets in the top 15. FTXH has 50 securities and a top 15 weight of 66.57%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026